WallStreetZenWallStreetZen

How to Buy Mimedx Group Stock

Mimedx Group Inc

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.

Mimedx Group stock last closed at $6.16, down 2.69% from the previous day, and has increased 83.33% in one year. It has overperformed other stocks in the Biotechnology industry by 1.1 percentage points. Mimedx Group stock is currently +83.06% from its 52-week low of $3.37, and -33.55% from its 52-week high of $9.27.

There are currently 146.96M MDXG shares outstanding. The market capitalization of MDXG is $905.26M. In the past 24 hours, 542,394 MDXG shares were traded.

How to Buy Mimedx Group Stock

Wondering how to invest in Mimedx Group stock? Here's how.
  1. Figure out where to buy Mimedx Group stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Mimedx Group stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Fund your investment account: Select your payment method and add your details.
  4. Analyze Mimedx Group stock: The Mimedx Group ticker symbol is MDXG. Is Mimedx Group stock a good investment? Should you buy shares of MDXG? How do MDXG's underlying business fundamentals look? Do top analysts think Mimedx Group is a good buy? Why has MDXG's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if MDXG is a good stock to buy).
  5. Make your MDXG trade: Decide if you will purchase MDXG shares at the current market price or use a limit order to buy MDXG stock at a particular price.
  6. Keep an eye on your investment in MDXG: Create a watchlist to track your position in Mimedx Group shares.

Step 1: Figure out where to buy Mimedx Group stock

You need a brokerage account in order to access the NASDAQ market and buy MDXG stock.

A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Technology to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the best brokerage, it's time to fill out some personal information so you are able to buy MDXG stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to open a new brokerage account.
  1. Submit your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have opened your account on apps for stocks, your next step is to transfer the money for your investment:

Check out this video walkthrough for more details depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Mimedx Group stock

After you have selected the best place to buy Mimedx Group stock, it's very important to evaluate their stock before you invest, so you can wrap your head around the risk and upside.

Overview of key MDXG info

MDXG Price
$6.16
1w %
-6.81%
1y %
83.33%
5y %
N/A
P/E
15.4x
P/B
6.34x
P/S
2.23x
PEG
0.6x
Revenue
$321.48M
Earnings
$58.23M
Fore. Rev. Growth
11.82%
Fore. Earn. Growth
25.46%
Market Cap
$905.26M
Next Earnings
Apr 30, 2024
Next Dividend
N/A

MDXG Due Diligence Checks

WallStreetZen was built to help average investors do more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on MDXG's stock page.

Is MDXG stock undervalued?

Analysts use many financial metrics, analyses, models, and charts to gauge MDXG's true value.

Using relative valuations methods:

  • MDXG could be undervalued based on its P/E ratio of 15.4x, relative to Biotechnology industry P/E ratio of 15.68x
  • MDXG may be overvalued based on its P/B ratio of 6.34x, relative to Biotechnology industry P/B ratio of 5.76x
  • MDXG could be undervalued based on its PEG ratio of 0.6x

You can do more valuation research on MDXG's stock here.

Is MDXG a healthy company?

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the MDXG balance sheet.
  • MDXG's operating cash flow of $26.78M allows it to safely service it's debt of $48.10M.
  • Total MDXG debt is lower than 5 years ago, relative to shareholder equity.
  • MDXG profit margin has gone up from -11.3% to 18.1% in the past year.
  • There are more short-term assets than short-term liabilities on the MDXG balance sheet.

Negative Health Checks:

  • MDXG has a relatively high debt to equity ratio of 0.68.
  • MDXG earnings of $27.88M is not sufficient to cover its interest payments.

Do Wall Street analysts think it's a good time to buy Mimedx Group stock

Out of 3 sell side analysts who monitor MDXG, the consensus analyst rating on MDXG is a Strong Buy

Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are projecting on the Mimedx Group stock forecast page.

Metrics for Advanced MDXG Traders

SMA10
6.56
SMA20
7.05
SMA50
7.67
SMA100
7.94
SMA200
7.54
MACD
-0.44
MACD Signal
-0.37
MACD Histogram
-0.07
RSI
25.41
Stochastic %K
3.95
Stochastic %D
3.34
StochRSI %K
11.33
StochRSI %D
6.18

MDXG Performance Metrics

Last year, MDXG revenue was $321.48M. In the past five year, MDXG's revenue has gone up by -2.19% per year. This was slower than the Biotechnology industry average of 28.98%.

Find out more about MDXG's earnings and revenue performance here.

What are MDXG executives and large shareholders up to?

In the past 12 months, insiders at MDXG have bought more shares than they have sold.

William Frank Hulse Iv, General Counsel and CAO of MDXG, was the latest MDXG insider to sell. They sold $61,382.40 worth of MDXG stock on Apr 8, 2024.

Learn more about who owns MDXG shares here.

Does MDXG stock generate passive income?

No, Mimedx Group doesn't provide an income stream by paying out dividends.

What do other investors have to say about MDXG?

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your MDXG trade

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a given dollar amount, place a limit order.

Press the Open button and eToro will place the order.

If you need more help buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep an eye on your investment in MDXG

Now that you own some MDXG stock, you'll want to keep up with your new shares.

Make a watchlist to get notified of important updates regarding your MDXG stock.

MDXG Feed

How to Buy Stock in Mimedx Group

To summarize, here are the 6 steps for buying Mimedx Group stock:

  1. Figure out where to buy Mimedx Group stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Analyze Mimedx Group stock
  5. Make your MDXG trade
  6. Keep an eye on your investment in MDXG

If you are looking for a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get the latest news on your new investment in Mimedx Group, get started below.

NASDAQ: MDXG
$6.16-0.17 (-2.69%)
Updated Apr 18, 2024
Open eToro Account
NASDAQ: MDXG
$6.16-0.17 (-2.69%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Mimedx Group share?

As of Apr 18, 2024, it costs $6.16 to buy one share of Mimedx Group stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.487 shares of MDXG.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Mimedx Group stock?

According to 3 Wall Street analysts who monitor Mimedx Group, their consensus recommendation is to buy Mimedx Group stock.

What is the best way to buy Mimedx Group stock?

One way to place an order for Mimedx Group stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.